Honasa Consumer, the parent company of Mamaearth and The Derma Co., has acquired a 58% stake in Fluence Pharma at an enterprise value of Rs 135 crore. The acquisition marks Honasa’s entry into India’s rapidly growing nutraceutical and wellness supplements market.
Key Highlights
- Honasa will acquire a 58% stake in Fluence Pharma.
- The deal values Fluence Pharma at Rs 135 crore.
- The remaining 42% stake will be acquired over the next 5-7 years.
- Honasa plans to set up a new subsidiary named Honasa Health Pvt Ltd.
- The acquisition strengthens the company’s presence beyond beauty and personal care.
Why This Deal Matters
Consumers are increasingly focusing on holistic wellness and “beauty-from-within” products. Seeing this trend, Honasa is expanding into science-backed nutritional supplements.
According to industry estimates, India’s nutraceutical market is worth more than Rs 16,000 crore and is expected to witness strong growth due to rising awareness about preventive healthcare and nutritional deficiencies.
About Fluence Pharma
Founded by Amit Bhusari and dermatologist Rajendra Singh Rajput, Fluence Pharma develops over-the-counter nutritional supplements for hair and skin conditions.
Popular Areas of Focus
- Hair fall management
- Skin health supplements
- Nutritional therapy products
- Beauty and wellness solutions
The company uses its patented Cyclical Nutrition Therapy (CNT) technology and has built a network of more than 3,000 dermatologists across India.
Strong Financial Performance
Fluence Pharma generated approximately Rs 40 crore in revenue during FY26 and reported an EBITDA margin of more than 20%, making it an attractive acquisition target for Honasa.
Honasa’s Growth Strategy
Through its new subsidiary, Honasa Health Pvt Ltd, the company plans to combine:
- Fluence Pharma’s clinical expertise.
- Honasa’s digital-first distribution network.
- Consumer insights and branding capabilities.
- Direct-to-consumer (D2C) growth strategies.
The move will allow Honasa to diversify its business beyond skincare and beauty products.
Future Outlook
The acquisition reflects a broader trend where beauty and personal care companies are entering the health and wellness space. As consumers increasingly seek science-backed supplements and preventive healthcare products, the nutraceutical segment is becoming one of India’s fastest-growing markets.
With the Fluence Pharma deal, Honasa aims to create a stronger “inside-out beauty” ecosystem and unlock new growth opportunities in the wellness industry.
